ELEVANCE HEALTH INC (ELV) Fundamental Analysis & Valuation

NYSE:ELV • US0367521038

Current stock price

311.18 USD
-2.17 (-0.69%)
At close:
314.8 USD
+3.62 (+1.16%)
After Hours:

This ELV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. ELV Profitability Analysis

1.1 Basic Checks

  • In the past year ELV was profitable.
  • ELV had a positive operating cash flow in the past year.
  • Each year in the past 5 years ELV has been profitable.
  • ELV had a positive operating cash flow in each of the past 5 years.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • The Return On Assets of ELV (4.66%) is better than 74.00% of its industry peers.
  • ELV's Return On Equity of 12.90% is fine compared to the rest of the industry. ELV outperforms 80.00% of its industry peers.
  • ELV has a better Return On Invested Capital (5.74%) than 61.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ELV is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROIC 5.74%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.84%, ELV is in the better half of the industry, outperforming 67.00% of the companies in the same industry.
  • ELV's Profit Margin has declined in the last couple of years.
  • ELV has a Operating Margin of 4.07%. This is comparable to the rest of the industry: ELV outperforms 57.00% of its industry peers.
  • ELV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.07%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ELV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
  • Compared to 1 year ago, ELV has less shares outstanding
  • ELV has less shares outstanding than it did 5 years ago.
  • ELV has a better debt/assets ratio than last year.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • ELV has a debt to FCF ratio of 10.10. This is a negative value and a sign of low solvency as ELV would need 10.10 years to pay back of all of its debts.
  • The Debt to FCF ratio of ELV (10.10) is worse than 60.00% of its industry peers.
  • A Debt/Equity ratio of 0.71 indicates that ELV is somewhat dependend on debt financing.
  • ELV has a Debt to Equity ratio of 0.71. This is comparable to the rest of the industry: ELV outperforms 51.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Altman-Z N/A
ROIC/WACC0.7
WACC8.23%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ELV Growth Analysis

3.1 Past

  • ELV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.49%.
  • ELV shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.12% yearly.
  • The Revenue has grown by 12.62% in the past year. This is quite good.
  • ELV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.32% yearly.
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.55% on average over the next years. This is quite good.
  • ELV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.69% yearly.
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.55%
Revenue Next Year-2.72%
Revenue Next 2Y0.09%
Revenue Next 3Y1.74%
Revenue Next 5Y2.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40 50

More info and screens

Find the best growth stocksShow best growing peers

5

4. ELV Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.31, the valuation of ELV can be described as reasonable.
  • Based on the Price/Earnings ratio, ELV is valued cheaper than 93.00% of the companies in the same industry.
  • ELV is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 11.89, the valuation of ELV can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ELV indicates a rather cheap valuation: ELV is cheaper than 85.00% of the companies listed in the same industry.
  • ELV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.20.
Industry RankSector Rank
PE 10.31
Fwd PE 11.89
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ELV is valued a bit cheaper than 75.00% of the companies in the same industry.
  • ELV's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 21.54
EV/EBITDA 9.4
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.69
EPS Next 2Y-1.04%
EPS Next 3Y4.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ELV Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.17%, ELV has a reasonable but not impressive dividend return.
  • ELV's Dividend Yield is rather good when compared to the industry average which is at 0.47. ELV pays more dividend than 92.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ELV has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • The dividend of ELV is nicely growing with an annual growth rate of 12.23%!
  • ELV has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.23%
Div Incr Years14
Div Non Decr Years14
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 27.00% of the earnings are spent on dividend by ELV. This is a low number and sustainable payout ratio.
  • The dividend of ELV is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP27%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ELV Fundamentals: All Metrics, Ratios and Statistics

ELEVANCE HEALTH INC

NYSE:ELV (4/15/2026, 8:04:00 PM)

After market: 314.8 +3.62 (+1.16%)

311.18

-2.17 (-0.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-28
Earnings (Next)04-22
Inst Owners93.83%
Inst Owner Change0.02%
Ins Owners0.15%
Ins Owner Change12.62%
Market Cap68.35B
Revenue(TTM)199.13B
Net Income(TTM)5.66B
Analysts74.29
Price Target392.72 (26.2%)
Short Float %1.81%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend6.82
Dividend Growth(5Y)12.23%
DP27%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)6.46%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)7.33%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)6
Avg EPS beat(8)1.93%
EPS beat(12)9
Avg EPS beat(12)1.87%
EPS beat(16)12
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.45%
Revenue beat(4)3
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-2%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)6
Avg Revenue beat(12)0.63%
Revenue beat(16)9
Avg Revenue beat(16)0.61%
PT rev (1m)-1.68%
PT rev (3m)-0.31%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)3.39%
EPS NY rev (1m)0.07%
EPS NY rev (3m)-4.16%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-5.04%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-5.97%
Valuation
Industry RankSector Rank
PE 10.31
Fwd PE 11.89
P/S 0.34
P/FCF 21.54
P/OCF 15.93
P/B 1.56
P/tB 15.76
EV/EBITDA 9.4
EPS(TTM)30.17
EY9.7%
EPS(NY)26.17
Fwd EY8.41%
FCF(TTM)14.45
FCFY4.64%
OCF(TTM)19.53
OCFY6.28%
SpS906.51
BVpS199.77
TBVpS19.75
PEG (NY)N/A
PEG (5Y)1.69
Graham Number368.253 (18.34%)
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROCE 7.18%
ROIC 5.74%
ROICexc 6.26%
ROICexgc 11.5%
OM 4.07%
PM (TTM) 2.84%
GM N/A
FCFM 1.59%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.74%
ROIC(5y)7.11%
ROICexc(3y)7.29%
ROICexc(5y)7.65%
ROICexgc(3y)13.44%
ROICexgc(5y)14.29%
ROCE(3y)8.45%
ROCE(5y)8.91%
ROICexgc growth 3Y-7.91%
ROICexgc growth 5Y-6.83%
ROICexc growth 3Y-6.71%
ROICexc growth 5Y-5.47%
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Debt/EBITDA 3.2
Cap/Depr 72.19%
Cap/Sales 0.56%
Interest Coverage 5.75
Cash Conversion 44.42%
Profit Quality 56.06%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.23%
ROIC/WACC0.7
Cap/Depr(3y)78.87%
Cap/Depr(5y)77.78%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.71%
Profit Quality(3y)81.36%
Profit Quality(5y)97.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
EPS Next Y-13.25%
EPS Next 2Y-1.04%
EPS Next 3Y4.72%
EPS Next 5Y8.55%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%
Revenue Next Year-2.72%
Revenue Next 2Y0.09%
Revenue Next 3Y1.74%
Revenue Next 5Y2.69%
EBIT growth 1Y-11.4%
EBIT growth 3Y-1.51%
EBIT growth 5Y1.02%
EBIT Next Year-1.32%
EBIT Next 3Y5.18%
EBIT Next 5Y6.59%
FCF growth 1Y-29.25%
FCF growth 3Y-24.06%
FCF growth 5Y-19.97%
OCF growth 1Y-25.29%
OCF growth 3Y-20.06%
OCF growth 5Y-16.69%

ELEVANCE HEALTH INC / ELV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to ELV.


Can you provide the valuation status for ELEVANCE HEALTH INC?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.


How profitable is ELEVANCE HEALTH INC (ELV) stock?

ELEVANCE HEALTH INC (ELV) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for ELV stock?

The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (ELV) is 10.31 and the Price/Book (PB) ratio is 1.56.


How sustainable is the dividend of ELEVANCE HEALTH INC (ELV) stock?

The dividend rating of ELEVANCE HEALTH INC (ELV) is 7 / 10 and the dividend payout ratio is 27%.